191 related articles for article (PubMed ID: 15630779)
1. Enfuvirtide doubles chances for suppression.
AIDS Patient Care STDS; 2004 Sep; 18(9):550. PubMed ID: 15630779
[No Abstract] [Full Text] [Related]
2. The optimal use of enfuvirtide.
Gallant JE
Hopkins HIV Rep; 2003 May; 15(3):1-3. PubMed ID: 12809103
[No Abstract] [Full Text] [Related]
3. Enfuvirtide access, administration, and patient education.
Celano SA
Hopkins HIV Rep; 2003 May; 15(3):1, 12. PubMed ID: 12809102
[No Abstract] [Full Text] [Related]
4. T-1249 development suspended.
Huff B
GMHC Treat Issues; 2003 Dec; 17(12):6. PubMed ID: 15011643
[No Abstract] [Full Text] [Related]
5. Darunavir offers potent new combo when used with enfuvirtide in ritonavir-boosted regimen.
Edmunds-Ogbuokiri T
HIV Clin; 2007; 19(1):1-3. PubMed ID: 17405221
[No Abstract] [Full Text] [Related]
6. Analysis of a switch from enfuvirtide to raltegravir in patients with undetectable viral load: efficacy and quality of life at 24 weeks.
Sayana S; Prosser P; Ricaurte JC; Sanchez S; Hamwi G; Hershey-Weber J; Chien C; Easley A; Nguyen T; Wilson L; Khanlou H
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(2):85-6. PubMed ID: 19369697
[No Abstract] [Full Text] [Related]
7. Use of darunavir and enfuvirtide in a pregnant woman.
Sued O; Lattner J; Gun A; Patterson P; Abusamra L; Cesar C; Fink V; Krolewiecki A; Cahn P
Int J STD AIDS; 2008 Dec; 19(12):866-7. PubMed ID: 19050223
[TBL] [Abstract][Full Text] [Related]
8. Consensus recommendation from a group of German experts for the use of enfuvirtide in heavily pretreated HIV patients.
Salzberger B; Däumer M; Gute P; Jaeger H; Knechten H; van Lunzen J; Mauss S; Mayr C; Moll A; Plettenberg A; Rockstroh J; Staszewski S; Stellbrink HJ; Stoll M; Sturmer M
Eur J Med Res; 2007 Mar; 12(3):93-102. PubMed ID: 17507306
[TBL] [Abstract][Full Text] [Related]
9. New partnership calls for clinical testing of two fusion inhibitors.
Slovick J
Posit Living; 1999 Aug; 8(7):15, 62. PubMed ID: 12492078
[No Abstract] [Full Text] [Related]
10. [Enfuvirtide. Two injections per day for HIV].
Taéron C
Rev Infirm; 2004 Oct; (104):35-6. PubMed ID: 15581312
[No Abstract] [Full Text] [Related]
11. Enfuvirtide (Fuzeon).
Proj Inf Perspect; 2003 Oct; (36):4-5. PubMed ID: 14696566
[TBL] [Abstract][Full Text] [Related]
12. Enfuvirtide beneficial in experienced patients.
AIDS Patient Care STDS; 2004 Jan; 18(1):57. PubMed ID: 15080095
[No Abstract] [Full Text] [Related]
13. Clinical trials for enfuvirtide (Fuzeon, T-20).
Crabb C
AIDS; 2003 Nov; 17(17):N13-4. PubMed ID: 15065580
[No Abstract] [Full Text] [Related]
14. Postmarketing use of enfuvirtide in veterans: provider compliance with criteria for use, overall efficacy, and tolerability.
Belperio PS; Mole LA; Halloran J; Boothroyd DB; Thomas IC; Backus LI
Ann Pharmacother; 2008 Nov; 42(11):1573-80. PubMed ID: 18940919
[TBL] [Abstract][Full Text] [Related]
15. Treatment with a new fusion inhibitor: patient issues with enfuvirtide (T-20). A review of the presentation at the satellite symposium "New hope: advancing care in HIV infection" at the 15th annual Association of Nurses in AIDS Care conference, November 2002.
Glutzer E
AIDS Read; 2003 Mar; 13(3 Suppl):S14-6. PubMed ID: 12765161
[TBL] [Abstract][Full Text] [Related]
16. Fuzeon treatment forum, January 2004.
Burgess GE
Surviv News (Atlanta Ga); 2004; 15(1):10. PubMed ID: 15032144
[No Abstract] [Full Text] [Related]
17. A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide.
Beatty G; Hunt P; Smith A; Hoh R; Huang W; Martin J; Deeks SG
Antivir Ther; 2006; 11(3):315-9. PubMed ID: 16759047
[TBL] [Abstract][Full Text] [Related]
18. [New drug class blocks virus-cell fusion. HIV not admitted].
MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584215
[No Abstract] [Full Text] [Related]
19. First-line use of enfuvirtide-containing HAART regimen with dramatic clinical and immunological improvement in three cases.
Bourgarit A; Lascoux C; Palmer P; Tuleja E; Pintado C; Farge D; Sereni D
AIDS; 2006 Feb; 20(3):471-3. PubMed ID: 16439888
[No Abstract] [Full Text] [Related]
20. The importance of sequencing in treatment options.
Berger DS
Posit Aware; 2001; 12(3):42-3. PubMed ID: 11686121
[No Abstract] [Full Text] [Related]
[Next] [New Search]